Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Prana P1 THC Activated Capsules in Healthy Volunteers
NCT03744091Phase 1Unknown
- Sponsor
- The University of the West Indies
- Start
- Jul 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Prana P1 THC in chronic pain (2 arms), sponsored by The University of the West Indies. Primary endpoints: Peak Plasma Concentration following 10 mg Prana P1 at 48 hours and Peak Plasma Concentration following 20 mg Prana P1 at 48 hours. Status: unknown.
02
Drugs
Prana P1 THC
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT03744091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03744091.